Henry Schein | HSIC - Cost Of Sales




Henry Schein reported $2.18B in Cost of Sales for its fiscal quarter ending in September of 2024.

Cost Of Sales Change Date
Agilent USD 785M 62M Oct/2024
Align Technology USD 298.28M 2.18M Dec/2024
Bruker USD 486.3M 40.7M Dec/2024
Cardinal Health USD 53.32B 2.95B Dec/2024
Charles River Laboratories USD 733.96M 91.97M Dec/2024
Cigna USD 59.19B 11.62B Dec/2024
Cooper Companies USD 340.7M 900K Oct/2024
CVS Health USD 206.29B 153.34B Dec/2024
Danaher USD 2.65B 251M Dec/2024
Dentsply International USD 456M 17M Sep/2024
Encompass Health USD 62.3M 1.7M Dec/2024
Henry Schein USD 2.18B 63M Sep/2024
Idexx Laboratories USD 383.63M 4.12M Dec/2024
IQVIA Holdings USD 2.58B 1.32B Dec/2024
Laboratory Of America USD 2.43B 55.5M Dec/2024
McKesson USD 92.04B 1.64B Dec/2024
Mettler Toledo International USD 405.81M 548.72M Dec/2024
Owens Minor USD 2.16B 34.57M Sep/2024
Patterson Companies USD 1.35B 0 Oct/2024
Quest Diagnostics USD 1.76B 91M Dec/2024
Revvity USD 317.08M 17.85M Dec/2024
Stryker USD 2.24B 261M Dec/2024
Tenet Healthcare USD 930M 4.19B Dec/2024
Thermo Fisher Scientific USD 6.49B 222M Dec/2024
Universal Health Services 2.3B 58.12M Sep/2024
Walgreens Boots Alliance USD 32.68B 1.39B Nov/2024
Waters USD 348.52M 46.86M Dec/2024
Zimmer Biomet Holdings USD 586.7M 48.1M Dec/2024
Zoetis USD 707M 6M Dec/2024